AT-Patch (ATP-C130/ATP-C70) vs Loss of Pulse Detection

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by ATsens Co.
VS

AI Verdict

These tools are adjacent rather than direct competitors, serving different primary purposes within cardiac monitoring. AT-Patch is designed for clinical-grade, long-term ECG monitoring and AI-powered arrhythmia diagnosis for medical professionals. In contrast, Fitbit's Loss of Pulse Detection is a consumer-focused safety feature that detects a potential loss of pulse and can automatically alert emergency services.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if you require extended, high-fidelity continuous ECG monitoring for diagnostic purposes, such as identifying intermittent arrhythmias over a period of up to 14 days. Its integrated AI analysis and shower-proof design make it ideal for comprehensive cardiac assessment in a clinical setting, ensuring patient comfort and accurate data collection.

View AT-Patch (ATP-C130/ATP-C70) →

Choose Loss of Pulse Detection if…

Choose Fitbit's Loss of Pulse Detection if the primary concern is immediate safety and emergency response for individuals at risk of sudden cardiac events. This feature is best suited for users who desire an automated system to detect a potential loss of pulse and alert emergency services if they become unresponsive, providing a critical layer of personal safety.

View Loss of Pulse Detection →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AT-Patch (ATP-C130/ATP-C70) Loss of Pulse Detection
Deployment Wearable device for patients; analysis software deployed on-premise at medical institutions. Unknown
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Loss of Pulse Detection

Tool B, as a feature integrated into compatible smartwatches, offers superior usability by leveraging a device many users already wear daily. This provides a seamless, 'always-on' experience without requiring the application or management of an additional dedicated device like Tool A's patch, despite Tool A's comfort-focused design.

Clinical Value

AT-Patch (ATP-C130/ATP-C70)

Tool A provides direct diagnostic clinical value by offering up to 14 days of continuous, high-accuracy ECG monitoring with AI-powered arrhythmia detection, directly aiding clinicians in diagnosing and managing cardiac conditions. While Tool B offers significant safety value through emergency alerts, it is a reactive safety feature rather than a proactive diagnostic tool for ongoing clinical assessment.

Pricing & Value

Loss of Pulse Detection

Tool B offers clear and transparent value as it is included as a feature with compatible Fitbit/Pixel devices, incurring no additional cost for the end-user beyond the device purchase. Tool A's pricing is not publicly available and involves direct sales to medical institutions, making its value proposition less transparent and harder to assess for individual users or smaller practices.

Enterprise Readiness

AT-Patch (ATP-C130/ATP-C70)

Tool A is designed for deployment with analysis software on-premise at medical institutions, indicating a clear focus on integration into healthcare enterprise workflows for patient diagnosis and data management. While Tool B is HIPAA compliant and has a BAA, it primarily functions as a consumer-facing feature that interfaces with emergency services, rather than a core system for healthcare providers.

Innovation

Loss of Pulse Detection

Tool B demonstrates significant innovation by leveraging existing consumer wearable technology (PPG and accelerometry) to provide an automated, potentially life-saving emergency response system for a critical event like loss of pulse. This proactive, automated emergency calling feature represents a novel application of AI in personal safety, whereas Tool A refines an existing diagnostic method with extended monitoring and AI analysis.

Support & Docs

Loss of Pulse Detection

Tool B, being a feature of a major consumer brand like Fitbit, benefits from an established and extensive support infrastructure, including online documentation, user manuals, and customer service channels readily accessible to a broad user base. Tool A, targeting medical institutions, likely has dedicated institutional support, but public information regarding its breadth and accessibility for individual users or clinicians is not available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AT-Patch (ATP-C130/ATP-C70) Loss of Pulse Detection
Name AT-Patch (ATP-C130/ATP-C70) Loss of Pulse Detection
Company ATsens Co. Fitbit
Primary Function / Monitoring Up to 14 days of continuous ECG monitoring (ATP-C130) Automatic loss of pulse detection
Key Technology / Sensors High-performance sensor chip for accurate ECG signal acquisition; Short-length electrode to minimize motion artifact noise Utilizes PPG and accelerometry sensors
AI/ML for Detection/Analysis AT-Report software with AI/machine learning algorithms for ECG analysis Used for automatic loss of pulse detection
Patient Interaction / Alerts AT-Note smartphone app for live ECG viewing and symptom recording Haptic and audio alerts to the user; Automated emergency service calling if unresponsive; Shares location with emergency services

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and Loss of Pulse Detection.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AT-Patch is designed for long-term continuous ECG monitoring, up to 14 days, to detect and analyze cardiac arrhythmias using AI-powered software. Fitbit's Loss of Pulse Detection, conversely, is an acute safety feature that identifies a potential loss of pulse and can automatically alert emergency services if the user is unresponsive.
AT-Patch utilizes electrocardiography (ECG) technology, which directly records the heart's electrical activity for high-accuracy signal acquisition and is considered the gold standard for heart rate and rhythm assessment. Fitbit's Loss of Pulse Detection uses photoplethysmography (PPG) and accelerometry sensors to detect changes in blood volume, indirectly reflecting heart rate and vascular health.
The AT-Patch offers continuous ECG monitoring for up to 14 days, with models available for 7 or 14 days. Fitbit's Loss of Pulse Detection is an always-on software feature integrated into compatible smartwatches, continuously monitoring for a loss of pulse while the device is worn.
AT-Patch uses on-premise AT-Report software with AI/machine learning algorithms for sophisticated ECG analysis, and patients can use the AT-Note smartphone app for live ECG viewing and symptom recording. Fitbit's Loss of Pulse Detection analyzes pulse and movement data to identify loss of pulse events, triggering alerts and, if unresponsive, automatically contacting emergency services and sharing location.
The AT-Patch is a compact, lightweight (13g), shower-proof wearable device that requires no charging or electrode replacement during its 14-day monitoring period, and patients can record symptoms via a smartphone app. Fitbit's Loss of Pulse Detection is an opt-in feature on compatible smartwatches that provides haptic and audio alerts to the user upon detection of a potential loss of pulse.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.